Literature DB >> 23853031

Risk factors for drug-resistant bacterial pneumonia in older patients hospitalized with pneumonia in a Chinese population.

H M Ma1, Margaret Ip, Jean Woo, David S C Hui, Grace C Y Lui, Nelson L S Lee, Paul K S Chan, T H Rainer.   

Abstract

BACKGROUND: The relationship between healthcare-associated pneumonia (HCAP) and resistant bacteria is unclear. The aim of this study was to identify the risk factors for pneumonia caused by drug-resistant bacteria (DRB).
METHODS: A prospective cohort study was conducted at a tertiary teaching hospital in Hong Kong. Consecutive older patients (aged ≥65 years) were hospitalized with pneumonia from January 2004 to June 2005. DRB comprised methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, extended-spectrum β-lactamase (ESBL) producing Enterobacteriaceae and Acinetobacter baumannii.
RESULTS: The entire cohort consisted of 1176 older patients. Of 472 (40.1%) patients with etiological diagnosis established, bacterial pneumonia was found in 354 (30.1%) cases. DRB were isolated in 48 patients: P. aeruginosa (41), MRSA (5) and ESBL producing enteric bacilli (3). Co-infection with P. aeruginosa and MRSA was found in one patient. The prevalence of DRB in culture-positive pneumonia was 20.1% (48/239). Patients with DRB were more likely to have limitation in activities of daily living, bronchiectasis, dementia, severe pneumonia, recent hospitalization and recent antibiotic use. Logistic regression revealed that bronchiectasis [relative risk (RR) 14.12, P = 0.002], recent hospitalization (RR 4.89, P < 0.001) and severe pneumonia (RR 2.42, P = 0.010) were independent predictors of drug-resistant bacterial pneumonia.
CONCLUSION: Recent hospitalization is the only risk factor for HCAP which is shown to be associated with DRB. Nursing home residence is not a risk factor. The concept of HCAP may not be totally applicable in Hong Kong where the prevalence of drug-resistant pathogens in pneumonia is low.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23853031     DOI: 10.1093/qjmed/hct152

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  4 in total

Review 1.  Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.

Authors:  Steven Y C Tong; Joshua S Davis; Emily Eichenberger; Thomas L Holland; Vance G Fowler
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

2.  Effects of Chengqi Decoction on Complications and Prognosis of Patients with Pneumonia-Derived Sepsis: Retrospective Cohort Study.

Authors:  Zhipeng Huang; Xiaoxin Cai; Yao Lin; Bojun Zheng; Li Jian; Yu Yi; Yang Guang
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-29       Impact factor: 2.629

3.  A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study.

Authors:  Andrew A Quartin; Ernesto G Scerpella; Sailaja Puttagunta; Daniel H Kett
Journal:  BMC Infect Dis       Date:  2013-11-27       Impact factor: 3.090

4.  Isolation of ESBL-producing Bacteria from Sputum in Community-acquired Pneumonia or Healthcare-associated Pneumonia Does Not Indicate the Need for Antibiotics with Activity against This Class.

Authors:  Hideyuki Horie; Isao Ito; Satoshi Konishi; Yuki Yamamoto; Yuko Yamamoto; Tatsuya Uchida; Hideo Ohtani; Yoshiharu Yoshida
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.